BAM
TMDX icon

Belpointe Asset Management’s Transmedics TMDX Stock Holding History

Belpointe Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-558
Closed -$42.3K – 3122
2023
Q1 		$42.3K Buy
558
+190
+52% +$13.1K ﹤0.01% 1805
2022
Q4 		$22.7K Buy
+368
New +$19.6K ﹤0.01% 2092

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Belpointe Asset Management's TMDX Position: Q2 2023 in Review

Belpointe Asset Management sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 558 shares — an estimated $42.3K sold.

Belpointe Asset Management first reported a position in TMDX in Q4 2022 and held it in 2 quarters. The position peaked at $42.3K in Q1 2023. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

  • Belpointe Asset Management reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 558 Transmedics shares in Q2 2023, an estimated $42.3K.
  • Belpointe Asset Management first reported a position in Transmedics in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Transmedics position peaked at $42.3K in Q1 2023.
  • 240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.